Is America on the brink of sparking a new flu pandemic?

**Lead**

A new wave of alarm is sweeping through the international scientific community as questions intensify over whether the United States is on the verge of inadvertently triggering the next influenza pandemic. The focus of concern is the controversial field of gain-of-function research, in which scientists genetically modify pathogens to make them more transmissible or virulent. While proponents argue this work is essential for pandemic preparedness, critics fear that the very technology designed to protect us may become the source of the next global health emergency. For the United Kingdom, which relies heavily on international collaboration and early warning systems, the stakes could not be higher.

**Context**

The debate over gain-of-function research is not new. In 2011, two laboratories—one in the Netherlands and one in the United States—created a highly transmissible form of the H5N1 avian influenza virus, sparking a global controversy over whether the benefits justified the risks. The US National Science Advisory Board for Biosecurity recommended redacting the full methodology from publications, a move that was eventually overturned. Since then, the US government has funded numerous similar projects through agencies such as the National Institutes of Health and the Department of Defense’s Biological Threat Reduction Programme.

More recently, the US Department of Health and Human Services implemented a new policy requiring additional review for certain gain-of-function experiments. However, critics argue that the oversight remains patchy and that loopholes allow potentially dangerous work to proceed without adequate public scrutiny. A 2023 review by the US Government Accountability Office found that biosafety incidents at high-containment laboratories have been underreported, raising further questions about the true scale of the risk.

The technology behind these experiments has advanced rapidly. Researchers now have tools such as CRISPR and synthetic biology that allow them to manipulate influenza genomes with unprecedented precision. While these techniques have legitimate uses in vaccine development and antiviral research, they also lower the barrier to creating dangerous novel pathogens. The World Health Organization has repeatedly called for a global framework to govern such research, but progress has been slow.

**Analysis**

For the United Kingdom, the implications are profound. The UK is home to several high-containment facilities, including the Pirbright Institute and the Porton Down laboratories, that collaborate with US counterparts. If a lab accident in America were to release a engineered flu strain with pandemic potential, the UK's public health infrastructure would be on the front line due to high travel volumes and close transatlantic ties. The UK Health Security Agency has previously modelled scenarios showing that a moderately transmissible novel influenza virus could overwhelm the National Health Service within weeks.

Moreover, the ethical dimension cannot be ignored. Gain-of-function research walks a tightrope between scientific progress and the precautionary principle. The technology itself is neutral, but the governance around it is not. The US currently lacks a legally binding, transparent system for evaluating the broader societal risks of these experiments. This contrasts with the UK's approach, where the Health and Safety Executive and the Advisory Committee on Dangerous Pathogens enforce strict regulations on all work with human pathogens.

Another worrying facet is the potential for dual-use. The same techniques that help scientists understand how a virus might evolve in nature could be weaponised by state or non-state actors. The US National Academies of Sciences, Engineering, and Medicine have warned that the current voluntary oversight system is insufficient to prevent misuse. In the UK, the Biological Weapons Act 1974 prohibits such work, but the global nature of science means that a dangerous pathogen created abroad could still reach British shores.

The technology debate is also entwined with international politics. Some US officials have argued that restricting gain-of-function research would cede strategic advantage to rivals such as China, which has its own programmes. Yet this zero-sum logic overlooks the collaborative nature of pandemic surveillance. A virus does not respect borders, and any outbreak would require multilateral cooperation to contain. The UK has called for a UN-led treaty on pandemic preparedness, but the US has been hesitant to commit to binding commitments.

**Sources**

This article draws on publicly available information from the World Health Organization, the US National Institutes of Health, the UK Health Security Agency, the US Government Accountability Office review on laboratory biosafety (2023), and reports published in the journals Nature and Science on gain-of-function research. No classified or unpublished data has been used.